Skip to main content
Premium Trial:

Request an Annual Quote

Randall Durnell, Kavita Reddy, Carl Hull, Kevin Cooksy, Julie Brooks, Brenda Rogers

Randall Durnell has been named vice president of commercial operations at GenTel Biosciences, the firm said this week.
Durnell previously held positions at Beckman Coulter, Aurora Biosciences, and Pierce Biotechnology.

CombiMatrix Molecular Diagnostics has hired Kavita Reddy to be its laboratory director. Reddy formerly was senior director of Genzyme Genetics Manhattan, and she was an associate director and scientific director of Quest Diagnostics.

Gen-Probe Chief Operating Officer Carl Hull will take on the additional title of president in March. Hull joined the company a year ago as executive vice president and COO. Hull formerly was VP and general manager of Applied Biosystems’ sequence detection system and microarrays business, and he previously was involved in sales and marketing at Ventana Medical Systems and at Abbott Laboratories.

Perlegen announced three new hires last week, naming Kevin Cooksy to be vice president of business development; Julie Brooks general counsel and corporate secretary; and Brenda Rogers to be VP of human resources.
Cooksy previously was involved in corporate development at Agilent Technologies; Brooks served in a variety of legal and corporate management positions at healthcare technology companies, including Westmark International and Access Health; and Rogers was a consultant to biotech companies and was VP of human resources at OneWorld Health.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.